• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Davita

Davita

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. UPDATE: Government pursues insider-trading case over 'political intelligence'

    UPDATE: Government pursues insider-trading case over 'political intelligence'

  2. UPDATE: Insider-trading charges brought over 'political intelligence' trades

    UPDATE: Insider-trading charges brought over 'political intelligence' trades

  3. UPDATE: Insider-trading charges brought over 'political intelligence' trades

    UPDATE: Insider-trading charges brought over 'political intelligence' trades

  4. Akebia Initiates Phase 2 FO2RWARD Study of Vadadustat in Dialysis Patients with Anemia Related to Chronic Kidney Disease Hyporesponsive to Treatment with Erythropoiesis-Stimulating Agents

    Akebia Initiates Phase 2 FO2RWARD Study of Vadadustat in Dialysis Patients with Anemia Related to Chronic Kidney Disease Hyporesponsive to Treatment with Erythropoiesis-Stimulating Agents

  5. Best Practices in Patient Recruitment - Research and Markets

    Best Practices in Patient Recruitment - Research and Markets

  6. United States Healthcare Services Market Report 2017 - Research and Markets

    United States Healthcare Services Market Report 2017 - Research and Markets

  7. European Hospitals and Outpatient Care Centers Market Report 2017 - Research and Markets

    European Hospitals and Outpatient Care Centers Market Report 2017 - Research and Markets

  8. Americas Hospitals and Outpatient Care Centers Market Report 2017 - Research and Markets

    Americas Hospitals and Outpatient Care Centers Market Report 2017 - Research and Markets

  9. Sale of Energy Stocks the Biggest Highlight in Berkshire's 4Q Equity Portfolio

    Warren Buffett’s Berkshire Hathaway had a shift in strategy in the fourth quarter as it unloaded most of its energy holdings to buy more of Deere and IBM.

  10. 10 High-Conviction Purchases by Our Ultimate Stock-Pickers

    Our top managers continue to find attractive buying opportunities in wide-moat firms.

12

©2017 Morningstar Advisor. All right reserved.